Highlights from ThoughtSpot 2022

Video
Conferences|ThoughtSpot

A quick video recap of all the sessions and events ThoughtSpot 2022 had to offer.

ThoughtSpot 2022 may be over, but this video highlights the events and opportunities from the event.

Recent Videos
Related Content
Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024

Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024

Killian Meara
November 20th 2024
Article

Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.

McKesson ideaShare: Wrapping Up The Week

McKesson ideaShare: Wrapping Up The Week

June 25th 2023
Podcast

Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.

Acoramidis Demonstrates Sustained Clinical Benefits in ATTR-CM

Acoramidis Demonstrates Sustained Clinical Benefits in ATTR-CM

Lauren Biscaldi, MS, Managing Editor
November 18th 2024
Article

A PDUFA date for acoramidis has been set for November 29, 2024.

Podcast: Your ThoughtSpot 2022 Day 2 Recap

Podcast: Your ThoughtSpot 2022 Day 2 Recap

July 23rd 2022
Podcast

From the Pharmacy of the Year winner announcement to a powerful Women in Pharmacy Workshop, here's what you missed on day 2 of ThoughtSpot.

How the Inflation Reduction Act Will Impact Pharmacy Reimbursement | ASPL 2024

How the Inflation Reduction Act Will Impact Pharmacy Reimbursement | ASPL 2024

Brian Nowosielski
November 14th 2024
Article

Pharmacy experts from AON Pharmacy in Florida discussed the Inflation Reduction Act and how it affects reimbursement for Medicare Part D drugs.

Q&A: Advantages of NADAC for Stakeholders in the Drug Supply Chain

Q&A: Advantages of NADAC for Stakeholders in the Drug Supply Chain

Killian Meara
November 13th 2024
Article

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

© 2024 MJH Life Sciences

All rights reserved.